3E0Y3HZ
3E0Y3HZ — Introduction of Radioactive Substance into Pericardial Cavity, Percutaneous Approach
Billable / specific codeICD-10-PCS
CMS abbreviated title: Introduce of Radioact Subst into Pericard Cav, Perc Approach
How 3E0Y3HZ is built
Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.
- 3SectionAdministration — What family of procedure this is
- EBody systemWhich system it acts on
- 0Root operationThe objective — the verb of the procedure
- YBody partThe specific site
- 3ApproachHow the site was reached
- HDeviceWhat was left in place, if anything
- ZQualifierA further distinction where one applies
Codes near 3E0Y3HZ
In CMS’s own ordering, which groups codes that differ by only the last character or two — usually the approach, device or qualifier.
- 3E0Y30MIntroduction of Antineoplastic, Monoclonal Antibody, into Pericardial Cavity, Percutaneous Approach
- 3E0Y328Introduction of Oxazolidinones into Pericardial Cavity, Percutaneous Approach
- 3E0Y329Introduction of Other Anti-infective into Pericardial Cavity, Percutaneous Approach
- 3E0Y33ZIntroduction of Anti-inflammatory into Pericardial Cavity, Percutaneous Approach
- 3E0Y36ZIntroduction of Nutritional Substance into Pericardial Cavity, Percutaneous Approach
- 3E0Y37ZIntroduction of Electrolytic and Water Balance Substance into Pericardial Cavity, Percutaneous Approach
- 3E0Y3BZIntroduction of Anesthetic Agent into Pericardial Cavity, Percutaneous Approach
- 3E0Y3GCIntroduction of Other Therapeutic Substance into Pericardial Cavity, Percutaneous Approach
- 3E0Y3HZIntroduction of Radioactive Substance into Pericardial Cavity, Percutaneous Approach
- 3E0Y3KZIntroduction of Other Diagnostic Substance into Pericardial Cavity, Percutaneous Approach
- 3E0Y3NZIntroduction of Analgesics, Hypnotics, Sedatives into Pericardial Cavity, Percutaneous Approach
- 3E0Y3SFIntroduction of Other Gas into Pericardial Cavity, Percutaneous Approach
- 3E0Y3TZIntroduction of Destructive Agent into Pericardial Cavity, Percutaneous Approach
- 3E0Y4GCIntroduction of Other Therapeutic Substance into Pericardial Cavity, Percutaneous Endoscopic Approach
- 3E0Y704Introduction of Liquid Brachytherapy Radioisotope into Pericardial Cavity, Via Natural or Artificial Opening
- 3E0Y705Introduction of Other Antineoplastic into Pericardial Cavity, Via Natural or Artificial Opening
- 3E0Y70MIntroduction of Antineoplastic, Monoclonal Antibody, into Pericardial Cavity, Via Natural or Artificial Opening